The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
CD3-specific antibody-induced active tolerance: from bench to bedside
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.303 · Cited by 2,233
Salomon, B., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., & Bluestone, J. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80195-8 · Cited by 2,081
Maini, R. N., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Davis, D., MACFARLANE, J. D., Antoni, C., Leeb, B. F., Elliott, M. J., Woody, J. N., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199809)41:9<1552::aid-art5>3.0.co;2-w · Cited by 1,623
Identification of a monoclonal antibody specific for a murine T3 polypeptide.
Leo, O., Foo, M., Sachs, D. H., Samelson, L. E., & Bluestone, J. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1374 · Cited by 1,593
Reshaping human antibodies for therapy
Riechmann, L., Clark, M., Waldmann, H., & Winter, G. (1988) · Nature · doi:10.1038/332323a0 · Cited by 1,562
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
Larsen, C. P., Elwood, E. T., Alexander, D. Z., Ritchie, S. C., Hendrix, R., Tucker-Burden, C., Cho, H. R., Aruffo, A., Hollenbaugh, D., Linsley, P. S., et al. (1996) · Nature · doi:10.1038/381434a0 · Cited by 1,455
Monoclonal Antibodies Defining Distinctive Human T Cell Surface Antigens
Kung, P. C., Goldstein, G., Reinherz, E. L., & Schlossman, S. F. (1979) · Science · doi:10.1126/science.314668 · Cited by 1,453
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.387 · Cited by 1,330
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012864 · Cited by 1,222
Itoh, M., Takahashi, T., Sakaguchi, N., Kuniyasu, Y., Shimizu, J., Otsuka, F., & Sakaguchi, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5317 · Cited by 1,211
Ohashi, P. S., Oehen, S., Buerki, K., Pircher, H., Ohashi, C. T., Odermatt, B., Malissen, B., Zinkernagel, R. M., & Hengartner, H. (1991) · Cell · doi:10.1016/0092-8674(91)90164-t · Cited by 1,173
Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg
Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S., & Bluestone, J. A. (1992) · Science · doi:10.1126/science.1323143 · Cited by 1,121
Anderson, P. C. (1999) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.281.24.2351 · Cited by 1,006
"Infectious" Transplantation Tolerance
Qin, S., Cobbold, S. P., Pope, H., Elliott, J., Kioussis, D., Davies, J., & Waldmann, H. (1993) · Science · doi:10.1126/science.8094901 · Cited by 871
Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation
Vincenti, F., Kirkman, R., Light, S., Bumgardner, G., Pescovitz, M., Halloran, P., Neylan, J., Wilkinson, A., Ekberg, H., Gaston, R., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380304 · Cited by 864
Suri-Payer, E., Amar, A. Z., Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1212 · Cited by 860
Yoshimoto, T., & Paul, W. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1285 · Cited by 841
Kirk, A. D., Burkly, L. C., Batty, D. S., Baumgartner, R. E., Berning, J. D., Buchanan, K., Fechner, J. H., Germond, R. L., Kampen, R. L., Patterson, N. B., et al. (1999) · Nature Medicine · doi:10.1038/9536 · Cited by 826
The T Cell Receptor/Cd3 Complex: A Dynamic Protein Ensemble
Clevers, H. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.629 · Cited by 791
Oldstone, M. B. A., Nerenberg, M., Southern, P., Price, J., & Lewicki, H. (1991) · Cell · doi:10.1016/0092-8674(91)90165-u · Cited by 751
Nashan, B., Moore, R., Amlot, P., Schmidt, A.-G., Abeywickrama, K., & Soulillou, J.-P. (1997) · The Lancet · doi:10.1016/s0140-6736(97)09278-7 · Cited by 749
OKT3: A monoclonal anti-human T lymphocyte antibody with potent mitogenic properties
Van Wauwe, J. P., DeMay, J. R., & Goossens, J. G. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.5.2359.a · Cited by 711
Ortho Multicenter Transplant Study Group* (1985) · New England Journal of Medicine · doi:10.1056/nejm198508083130601 · Cited by 708
Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.
Chatenoud, L., Thervet, E., Primo, J., & Bach, J. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.123 · Cited by 664
Self-citationElliott, M. J., Maini, R. N., Feldmann, M., Long-Fox, A., Charles, P., Bijl, J. A., & Woody, J. N. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90632-7 · Cited by 640
OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties.
Van Wauwe, J. P., De Mey, J. R., & Goossens, J. G. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.6.2708 · Cited by 582
Cosimi, A. B., Colvin, R. B., Burton, R. C., Rubin, R. H., Goldstein, G., Kung, P. C., Hansen, W. P., Delmonico, F. L., & Russell, P. S. (1981) · New England Journal of Medicine · doi:10.1056/nejm198108063050603 · Cited by 505
CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice
Chatenoud, L., Primo, J., & Bach, J. F. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2947 · Cited by 417
Self-citationTREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH OKT3 MONOCLONAL ANTIBODY
Cosimi, A. B., BURTON, R. C., COLVIN, R. B., GOLDSTEIN, G., DELMONICO, F. L., LAQUAGLIA, M. P., TOLKOFF-RUBIN, N., RUBIN, R. H., HERRIN, J. T., & RUSSELL, P. S. (1981) · Transplantation · doi:10.1097/00007890-198112000-00018 · Cited by 389
ABRAMOWICZ, D., SCHANDENE, L., GOLDMAN, M., CRUSIAUX, A., VEREERSTRAETEN, P., PAUW, L. D., WYBRAN, J., KINNAERT, P., DUPONT, E., & TOUSSAINT, C. (1989) · Transplantation · doi:10.1097/00007890-198904000-00008 · Cited by 352
Immunotherapy of the Nonobese Diabetic Mouse: Treatment with an Antibody to T-Helper Lymphocytes
Shizuru, J. A., Taylor-Edwards, C., Banks, B. A., Gregory, A. K., & Fathman, C. G. (1988) · Science · doi:10.1126/science.2966437 · Cited by 345
Perturbation of the T4 molecule transmits a negative signal to T cells.
Bank, I., & Chess, L. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.4.1294 · Cited by 328
Induction of classical transplantation tolerance in the adult.
Qin, S. X., Cobbold, S., Benjamin, R., & Waldmann, H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.3.779 · Cited by 317
How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model
von Herrath, M. G., Dockter, J., & Oldstone, M. B. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90101-5 · Cited by 304
Induction of tolerance by monoclonal antibody therapy
Benjamin, R. J., & Waldmann, H. (1986) · Nature · doi:10.1038/320449a0 · Cited by 299
(1989) · New England Journal of Medicine · doi:10.1056/nejm198905253202117 · Cited by 269
Ferran, C., Sheehan, K., Dy, M., Schreiber, R., Merite, S., Landais, P., Noel, L., Grau, G., Bluestone, J., Bach, J., et al. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200308 · Cited by 264
Self-citationSakaguchi, S., Takahashi, T., & Nishizuka, Y. (1982) · The Journal of experimental medicine · doi:10.1084/jem.156.6.1565 · Cited by 225
Bolt, S., Routledge, E., Lloyd, I., Chatenoud, L., Pope, H., Gorman, S. D., Clark, M., & Waldmann, H. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230216 · Cited by 218
Self-citationHuman in vivo antigenic modulation induced by the anti‐T cell OKT3 monoclonal antibody
Chatenoud, L., Baudrihaye, M. F., Kreis, H., Goldstein, G., Schindler, J., & Bach, J. (1982) · European Journal of Immunology · doi:10.1002/eji.1830121116 · Cited by 201
Self-citationHirsch, R., Gress, R. E., Pluznik, D. H., Eckhaus, M., & Bluestone, J. A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.3.737 · Cited by 199
Smith, J. A., Tso, J. Y., Clark, M. R., Cole, M. S., & Bluestone, J. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.8.1413 · Cited by 192
Woodle, E. S., Xu, D., Zivin, R. A., Auger, J., Charette, J., O'Laughlin, R., Peace, D., Jolliffe, L. K., Haverty, T., Bluestone, J. A., et al. (1999) · Transplantation · doi:10.1097/00007890-199909150-00003 · Cited by 188
Spits, H., Yssel, H., Leeuwenberg, J. F. M., & de Vries, J. E. (1985) · European Journal of Immunology · doi:10.1002/eji.1830150117 · Cited by 172
Alegre, M.-L., Peterson, L. J., Xu, D., Sattar, H. A., Jeyarajah, D. R., Kowalkowski, K., Thistlethwaite, J. R., Zivin, R. A., Jolliffe, L., & Bluestone, J. A. (1994) · Transplantation · doi:10.1097/00007890-199457110-00001 · Cited by 171
Hirsch, R., Eckhaus, M., Auchincloss, H., Sachs, D. H., & Bluestone, J. A. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.11.3766 · Cited by 167
Pearson, T. C., Madsen, J. C., Larsen, C. P., Morris, P. J., & Wood, K. J. (1992) · Transplantation · doi:10.1097/00007890-199209000-00018 · Cited by 151
Nicolls, M. R., Aversa, G., PEARCE, N. W., SPINELLI, A., Berger, M. F., Gurley, K. E., & Hall, B. M. (1993) · Transplantation · doi:10.1097/00007890-199303000-00001 · Cited by 145
PHASE I STUDY OF AN ENGINEERED AGLYCOSYLATED HUMANIZED CD3 ANTIBODY IN RENAL TRANSPLANT REJECTION1
Friend, P. J., Hale, G., Chatenoud, L., Rebello, P., Bradley, J. R., Thiru, S. S., Phillips, J. M., & Waldmann, H. (1999) · Transplantation · doi:10.1097/00007890-199912150-00005 · Cited by 145
Self-citationPrevention of Autoimmune Diabetes With Nonactivating Anti-CD3 Monoclonal Antibody
Herold, K. C., Bluestone, J. A., MONTAG, A. G., Parih, A., Wiegner, A., Gress, R. E., & Hirsch, R. (1992) · Diabetes · doi:10.2337/diab.41.3.385 · Cited by 138
Treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody
Gilbert, E. M., Dewitt, C. W., Eiswirth, C. C., Renlund, D. G., Menlove, R. L., Freedman, L. A., Herrick, C. M., Gay, W. A., & Bristow, M. R. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90056-8 · Cited by 134
Monaco, A. P., WOOD, M. L., & Russell, P. S. (1966) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1966.tb12851.x · Cited by 131
Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial.
Utset, T. O., Auger, J., Peace, D., Zivin, R. A., Xu, D., Jolliffe, L. K., Alegre, M., Bluestone, J. A., & Clark, M. R. (2002) · PubMed · Cited by 131
Hirsch, R., Bluestone, J. A., DENENNO, L., & Gress, R. E. (1990) · Transplantation · doi:10.1097/00007890-199006000-00018 · Cited by 124
Durez, P., Abramowicz, D., Gerard, C. M., van Mechelen, M., Amraoui, Z., Dubois, C., Léo, O., Velu, T. J., & Goldman, M. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.2.551 · Cited by 119
Vigeral, P., Chkoff, N., Chatenoud, L., Campos, H. D. H., LACOMBE, H. M., Droz, D., Goldstein, G., Bach, J., & Kreis, H. (1986) · Transplantation · doi:10.1097/00007890-198606000-00013 · Cited by 113
Self-citationSeewaldt, S., Thomas, H. E., Ejrnaes, M., Christen, U., Wolfe, T., Rodrigo, E., Coon, B., Michelsen, B. K., Kay, T. W. H., & von Herrath, M. G. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1801 · Cited by 112
ONE-MONTH PROPHYLACTIC USE OF OKT3 IN CADAVER KIDNEY TRANSPLANT RECIPIENTS
Debure, A., Chkoff, N., Chatenoud, L., Lacombe, M., Campos, H. D. H., Noël, L., Goldstein, G., Bach, J., & Kreis, H. (1988) · Transplantation · doi:10.1097/00007890-198803000-00009 · Cited by 104
Self-citationSmith, J. A., Tang, Q., & Bluestone, J. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4841 · Cited by 101
The Human Immune Response to the OKT3 Monoclonal Antibody Is Oligoclonal
Chatenoud, L., Jonker, M., Villemain, F., Goldstein, G., & Bach, J. (1986) · Science · doi:10.1126/science.3086976 · Cited by 98
Self-citationNon-Fc Receptor-Binding Humanized Anti-CD3 Antibodies Induce Apoptosis of Activated Human T Cells
Carpenter, P. A., Pavlovic, S., Tso, J. Y., Press, O. W., Gooley, T. A., Yu, X., & Anasetti, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6205 · Cited by 97
Suri‐Payer, E., Kehn, P. J., Cheever, A. W., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1799 · Cited by 88
Wood, M. L., Monaco, A. P., Gozzo, J. J., & Liégeois, A. (1971) · PubMed · Cited by 82
Alegre, M., Vandenabeele, P., Flamand, V., Moser, M., Léo, O., Abramowicz, D., Urbain, J., Fiers, W., & Goldman, M. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200337 · Cited by 82
Charpentier, B., HIESSE, C., Lantz, O. J., Ferran, C. J., Stephens, S., OʼSHAUGNESSY, D., Bodmer, M., Benoît, G., Bach, J., & Chatenoud, L. (1992) · Transplantation · doi:10.1097/00007890-199212000-00011 · Cited by 78
Self-citationAnti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.
Ferran, C. J., Dautry, F., Merite, S., Sheehan, K. C. F., Schreiber, R. D., Grau, G. E., Bach, J., & Chatenoud, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117215 · Cited by 77
Self-citationGoldstein, G. (1987) · PubMed · Cited by 77
Plain, K. M., Chen, J., Merten, S. L., He, X. Y., & Hall, B. M. (1999) · Transplantation · doi:10.1097/00007890-199902270-00020 · Cited by 76
Anaphylactic Shock after Retreatment with OKT3 Monoclonal Antibody
Abramowicz, D., Crusiaux, A., & Goldman, M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271018 · Cited by 71
Abramowicz, D., Goldman, M., Pauw, L. D., Vanherweghem, J. L., Kinnaert, P., & Vereerstraeten, P. (1992) · Transplantation · doi:10.1097/00007890-199209000-00009 · Cited by 70
FREY, D. J., Matas, A. J., Gillingham, K. J., Canafax, D. M., Payne, W. D., Dunn, D. L., Sutherland, D. E. R., & Najarian, J. S. (1992) · Transplantation · doi:10.1097/00007890-199207000-00008 · Cited by 61
Jabado, N., Pallier, A., Deist, F. L., Bernard, F., Fischer, A., & Hivroz, C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.94 · Cited by 60
A humanized monovalent CD3 antibody which can activate homologous complement
Routledge, E. G., LLOYD, I. S., Gorman, S. D., Clark, M., & Waldmann, H. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211111 · Cited by 52
In vivo effects of IgA and IgG2a anti-CD3 isotype switch variants.
Parlevliet, K. J., ten Berge, I. J. M., Yong, S. L., Surachno, J. S., Wilmink, J. M., & Schellekens, P. T. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117262 · Cited by 47
Routledge, E. G., FALCONER, M. E., Pope, H., LLOYD, I. S., & Waldmann, H. (1995) · Transplantation · doi:10.1097/00007890-199510000-00015 · Cited by 46
Induction of cytotoxicity in human peripheral blood mononuclear cells by monoclonal antibody OKT3.
Jung, G., Martin, D. E., & Müller‐Eberhard, H. J. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.2.639 · Cited by 43
Lazarovits, A. I., Rochon, J., Banks, L., Hollomby, D. J., Muirhead, N., Jevnikar, A. M., White, M. J., Amlot, P. L., Beauregard-Zollinger, L., & STILLER, C. R. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.11.5163 · Cited by 43
Inter-mouse strain differences in thein vivoanti-CD3 induced cytokine release
Ferran, C. J., Dy, M., Sheehan, K. C. F., Merite, S., Schreiber, R. D., Landais, P., Grau, G. E., Bluestone, J. A., Bach, J., & Chatenoud, L. (1991) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1991.tb02966.x · Cited by 42
Self-citationFarges, O., Ericzon, B., Bresson‐Hadni, S., Lynch, S. V., Höckerstedt, K., Houssin, D. P., Galmarini, D., Faure, J.-L., Baldauf, C., & Bismuth, H. (1994) · Transplantation · doi:10.1097/00007890-199410270-00006 · Cited by 34
Abbs, I. C., Clark, M., Waldmann, H., Chatenoud, L., Koffman, C. G., & Sacks, S. H. (1994) · PubMed · Cited by 14
Self-citationBroyer, M., Gagnadoux, M., Guest, G., Arsan, A., Beurton, D., Révillon, Y., & Niaudet, P. (1993) · PubMed · Cited by 11
Regulation of fucosyltransferase-VII expression in peripheral lymph node high endothelial venules
(1998) · doi:10.1002/(sici)1521-4141(199810)28:10
Cited by
Bispecific antibodies: a mechanistic review of the pipeline
Labrijn, A. F., Janmaat, M. L., Reichert, J. M., & Parren, P. W. H. I. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0028-1 · Cited by 1,303
Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans
Grazia Roncarolo, M., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K., & Levings, M. K. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00420.x · Cited by 1,173
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
Keymeulen, B., Vandemeulebroucke, E., Ziegler, A. G., Mathieu, C., Kaufman, L., Hale, G., Gorus, F., Goldman, M., Walter, M., Candon, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043980 · Cited by 1,099
Self-citationCD3-specific antibodies: a portal to the treatment of autoimmunity
Chatenoud, L., & Bluestone, J. A. (2007) · Nature Reviews Immunology · doi:10.1038/nri2134 · Cited by 388
Self-citationHuman CD4+CD25+ regulatory T cells
Baecher-Allan, C. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.12.005 · Cited by 385
Metadata
- Authors
- Chatenoud, L.
- Venue
- Nature Reviews Immunology
- Published
- 2003-02
- Volume
- 3
- Issue
- 2
- Pages
- 123-132
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2082254478
- Cited by
- 309
- References
- 84
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.